Abstract
We describe a real-time PCR-based assay capable of simultaneously detecting femA (Staphylococcus aureus-specific), mecA (methicillin resistance), qacA/B (chlorhexidine tolerance), and mupA (high-level mupirocin resistance) from bacterial cells in less than 90 minutes. The assay was validated with 1968 clinical MRSA submitted to a surveillance network.
Keywords:
Chlorhexidine; MRSA; MupA; Mupirocin; QacA.
© 2013.
Publication types
-
Research Support, U.S. Gov't, Non-P.H.S.
-
Validation Study
MeSH terms
-
Anti-Bacterial Agents / pharmacology
-
Bacterial Proteins / genetics*
-
Chlorhexidine / pharmacology
-
Drug Resistance, Bacterial*
-
Humans
-
Membrane Transport Proteins / genetics*
-
Methicillin-Resistant Staphylococcus aureus / genetics*
-
Methicillin-Resistant Staphylococcus aureus / isolation & purification
-
Mupirocin / pharmacology
-
Nuclear Proteins / genetics*
-
Polymerase Chain Reaction / methods*
-
Staphylococcal Infections / microbiology*
-
Time Factors
Substances
-
Anti-Bacterial Agents
-
Bacterial Proteins
-
FemA protein, Bacteria
-
Membrane Transport Proteins
-
Nuclear Proteins
-
QacB protein, Staphylococcus aureus
-
mupA protein, Staphylococcus aureus
-
qacA protein, Staphylococcus aureus
-
Mupirocin
-
Chlorhexidine